D
DiaMedica Therapeutics Inc. DMAC
$8.51 $0.182.16% NASDAQ
Recommendation
Prev Close
$8.51
Volume
267,616
Avg Vol (90D)
374,332
Market Cap
$455.95M
Dividend & Yield
--
52-Week Range
$3.19 - $10.42
P/E (TTM)
--
EPS (TTM)
-$0.72
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
DiaMedica Therapeutics (DMAC, $8.51) entered Uptrend as Momentum indicator ascends above 0 level on Jan 23, 2026
1/24/2026 - Tickeron - Technical Analysis
Insiders continue to buy DiaMedica Therapeutics Inc. (NASDAQ:DMAC) and now own 47% shares
1/24/2026 - Simply Wall St
DiaMedica Therapeutics (DMAC, $8.33) Stochastic Oscillator left the oversold zone on January 22, 2026
1/23/2026 - Tickeron - Stocks
DiaMedica Therapeutics (DMAC, $8.33) price moved above its 50-day Moving Average on January 22, 2026
1/23/2026 - Tickeron - Stocks
Cantor Fitzgerald Sticks to Its Buy Rating for Diamedica Therapeutics (DMAC)
1/22/2026 - TipRanks Financial Blog
Short Interest in DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Declines By 22.8%
1/18/2026 - MarketBeat
DiaMedica Therapeutics (DMAC, $7.58) price may climb as it broke lower Bollinger Band on Jan 16, 2026
1/17/2026 - Tickeron - Stocks
DiaMedica Therapeutics (DMAC, $7.58) price exceeded its 50-day Moving Average on January 16, 2026
1/17/2026 - Tickeron - Stocks
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/16/2026 - Business Wire
Analysts Set DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Price Target at $12.33
1/16/2026 - Ticker Report
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Rating of "Moderate Buy" from Brokerages
1/13/2026 - MarketBeat
DiaMedica Therapeutics (NASDAQ:DMAC) Stock Price Down 2.3% - Should You Sell?
1/10/2026 - MarketBeat
DiaMedica Therapeutics (DMAC, $8.54) entered Uptrend as Momentum indicator ascends above 0 level on Jan 05, 2026
1/6/2026 - Tickeron - Technical Analysis
DiaMedica Therapeutics (DMAC, $8.54) Stochastic Oscillator left the oversold zone on January 05, 2026
1/6/2026 - Tickeron - Technical Analysis
DiaMedica Therapeutics (DMAC) Seen as Strong Performer with Upcoming Catalysts
1/5/2026 - GuruFocus
DiaMedica Therapeutics named a Top Idea for 2026 at Lake Street
1/5/2026 - The Fly
Craig-Hallum Reaffirms Their Buy Rating on Diamedica Therapeutics (DMAC)
12/20/2025 - TipRanks Financial Blog
The volume for DiaMedica Therapeutics stock increased for one day, resulting in a record-breaking daily growth of 322% of the 65-Day Volume Moving Average
12/19/2025 - Tickeron - Stocks
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Given Consensus Recommendation of "Moderate Buy" by Brokerages
12/19/2025 - MarketBeat
DiaMedica Therapeutics provides DM199 update following FDA meeting
12/18/2025 - The Fly
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
12/18/2025 - GuruFocus
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
12/18/2025 - Business Wire
Here's Why We're Not Too Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Situation
12/18/2025 - Simply Wall St
DiaMedica Therapeutics (DMAC, $8.76) Moving Average Convergence Divergence (MACD) Histogram turned negative on December 16, 2025
12/17/2025 - Tickeron - Stocks
DiaMedica Therapeutics (DMAC, $8.67) RSI Indicator left the overbought zone on December 15, 2025
12/16/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$33.56M
EBIT (TTM)
-$33.60M
Net Income (TTM)
-$31.93M
Balance Sheet
Total Assets (Q)
$57.05M
Total Debt (Q)
$266.00K
Total Liabilities (Q)
$5.43M
Book Value Per Share (Q)
$0.9913
Cash Flow
Cash from Operations (TTM)
-$27.73M
Cash from Investing (TTM)
-$4.98M
Cash from Financing (TTM)
$31.91M
Net Change in Cash (TTM)
-$808.00K
Filings
Filing Date
Wednesday, November 12, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 16 and 20 (est)
Price History
Loading...
Beta
1.08
7-Day Total Return
-1.05%
30-Day Total Return
-8.98%
60-Day Total Return
25.33%
90-Day Total Return
22.09%
Year to Date Total Return
7.31%
1-Year Total Return
35.08%
2-Year Total Return
217.54%
3-Year Total Return
459.87%
5-Year Total Return
-8.59%
52-week Low
Apr 07, 2025 - $3.19
52-week High
Dec 10, 2025 - $10.42
Valuation
Market Cap
$455.95M - Small Cap
Enterprise Value
$400.90M
Price/Sales (TTM)
--
Price/Book (Q)
8.58
Dividends and Shares
Shares Outstanding
49.63M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.diamedica.com
Phone Number
763 496 5454
Address
301 Carlson Parkway
Minneapolis, MN 55305
Country
United States
Year Founded
2000
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a... more
NASDAQ 01/23/2026 4:00PM Eastern Quotes delayed